These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22589230)

  • 1. Dietary supplement drug therapies for depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Jun; 50(6):13-6. PubMed ID: 22589230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutraceutical Augmentation Strategies for Depression: A Narrative Review.
    Lande RG
    J Am Osteopath Assoc; 2020 Feb; 120(2):100-106. PubMed ID: 31985760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(4):1000-50. PubMed ID: 11010621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using complementary and alternative medicines for depression.
    Fava M
    J Clin Psychiatry; 2010 Sep; 71(9):e24. PubMed ID: 20923617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US Dietary Supplement Labeling Rules and the Possibility of Medical Cost Reduction.
    Amagase H
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S136-8. PubMed ID: 26598828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments.
    Ravindran AV; Lam RW; Filteau MJ; Lespérance F; Kennedy SH; Parikh SV; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S54-64. PubMed ID: 19666194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009; 70 Suppl 5():18-22. PubMed ID: 19909689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dietary Supplement and Health Education Act and supplements: dietary and nutritional supplements need no more regulations.
    Wollschlaeger B
    Int J Toxicol; 2003; 22(5):387-90. PubMed ID: 14555412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-methylfolate (Deplin®): a new medical food therapy as adjunctive treatment for depression.
    Roman MW; Bembry FH
    Issues Ment Health Nurs; 2011; 32(2):142-3. PubMed ID: 21247282
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient use of dietary supplements: a clinician's perspective.
    Sadovsky R; Collins N; Tighe AP; Brunton SA; Safeer R
    Curr Med Res Opin; 2008 Apr; 24(4):1209-16. PubMed ID: 18348745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids in major depressive disorder.
    Freeman MP
    J Clin Psychiatry; 2009; 70 Suppl 5():7-11. PubMed ID: 19909687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Other therapeutic strategies].
    Saba G; Nieto I; Bation R; Allaïli N; Bennabi D; Moliere F; Richieri R; Holtzmann J; Bubrovszky M; Camus V; Charpeaud T; Courtet P; Courvoisier P; Haesebaert F; Doumy O; El-Hage W; Garnier M; d'Amato T; Bougerol T; Lançon C; Haffen E; Llorca PM; Vaiva G; Bellivier F; Leboyer M; Aouizerate B
    Presse Med; 2016 Mar; 45(3):350-9. PubMed ID: 26995510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the dietary supplement S-adenosyl-L-methionine.
    Fetrow CW; Avila JR
    Ann Pharmacother; 2001 Nov; 35(11):1414-25. PubMed ID: 11724095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dispelling the myths about omega-3 fatty acids.
    Sadovsky R; Collins N; Tighe AP; Safeer RS; Morris CM; Brunton SA
    Postgrad Med; 2008 Jul; 120(2):92-100. PubMed ID: 18654074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrient-based therapies for bipolar disorder: a systematic review.
    Sylvia LG; Peters AT; Deckersbach T; Nierenberg AA
    Psychother Psychosom; 2013; 82(1):10-9. PubMed ID: 23147067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [S-adenosyl L-methionine in CNS diseases].
    Krzystanek M; Pałasz A; Krzystanek E; Krupka-Matuszczyk I; Wiaderkiewicz R; Skowronek R
    Psychiatr Pol; 2011; 45(6):923-31. PubMed ID: 22335134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are nutritional supplements ready for prime time?
    Mischoulon D; Fava M
    J Clin Psychiatry; 2008 Sep; 69(9):1497-8. PubMed ID: 19193349
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective.
    Collins N; Tighe AP; Brunton SA; Kris-Etherton PM
    J Am Coll Nutr; 2008 Dec; 27(6):659-66. PubMed ID: 19155425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.